Target intelligence / Profile preview

Muscleblind-like protein 1-expanded RNA repeat complex (MBNL1-RNA complex)

Target
MBNL1-RNA complex
Molecular classification
RNA-binding protein complex, Ribonucleoprotein complex
01

Overview

The Muscleblind-like protein 1 (MBNL1)-expanded RNA repeat complex is a pathological ribonucleoprotein assembly central to the pathogenesis of Myotonic Dystrophy (DM) (Miller et al., 2000; Kanadia et al., 2003). In DM, expanded CUG or CCUG repeats in the 3' untranslated region of the DMPK or CNBP genes form stable hairpin structures that sequester MBNL1 within nuclear foci (UniProt Q9NR56). This sequestration leads to a functional loss of MBNL1, a critical regulator of alternative splicing, resulting in the mis-splicing of numerous downstream transcripts such as CLCN1 and INSR (NIH/GARD). Therapeutic strategies targeting this complex aim to either degrade the toxic expanded RNA or use small molecules to competitively inhibit the MBNL1-RNA interaction, thereby liberating the protein to restore normal cellular function (Warf et al., 2009). Restoring MBNL1 activity is expected to alleviate the multisystemic symptoms of DM, including myotonia, muscle wasting, and cardiac conduction defects. However, challenges include achieving high specificity for the expanded repeats over other RNA sequences and ensuring efficient delivery to affected tissues like skeletal and cardiac muscle.

Other names
MBNL1-CUG repeat complexMBNL1-CCUG repeat complexMBNL1-RNA fociMBNL1-CUGexp complex
02

Mechanism of action

Disruption of the MBNL1-RNA complex to release sequestered MBNL1 and restore normal alternative splicing patterns.

03

Biological functions

Alternative splicing regulationRNA metabolismmRNA localizationmRNA stability
04

Disease associations

Myotonic dystrophy type 1Myotonic dystrophy type 2
05

Safety considerations

Off-target RNA bindingSystemic toxicity of small molecule displacersTissue-specific delivery challenges to skeletal and cardiac muscle
06

Interacting drugs

Pentamidine

3 more in the full profile.

07

Biomarkers

MBNL1 nuclear foci countCLCN1 splicing indexINSR splicing indexMBNL1 protein localization

Beyond the preview

Go deeper on Muscleblind-like protein 1-expanded RNA repeat complex (MBNL1-RNA complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscleblind-like protein 1-expanded RNA repeat complex (MBNL1-RNA complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call